Cedar Point Capital Partners
LLY icon

Cedar Point Capital Partners’s Eli Lilly LLY Stock Holding History

Cedar Point Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$451K Buy
390
+53
+16% +$62.5K 0.26% 49
2026
Q2 		$404K Buy
337
+62
+23% +$63.3K 0.23% 53
2026
Q1 		$253K Buy
275
+35
+15% +$35.5K 0.16% 65
2025
Q4 		$258K Buy
+240
New +$229K 0.16% 62

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Cedar Point Capital Partners's LLY Position: Q3 2026 in Review

Cedar Point Capital Partners increased its Eli Lilly (LLY) stake by 16% in Q3 2026, buying an estimated $62.5K and bringing the position to 390 shares worth $451K. The position accounts for 0.26% of the portfolio, ranked #49.

Cedar Point Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,563 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cedar Point Capital Partners held 390 shares of Eli Lilly worth $451K as of Q3 2026.
  • Cedar Point Capital Partners bought 53 Eli Lilly shares in Q3 2026, an estimated $62.5K.
  • Eli Lilly made up 0.26% of Cedar Point Capital Partners's portfolio in Q3 2026, its #49 holding.
  • Cedar Point Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 2,563 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cedar Point Capital Partners's 13F filing for Q3 2026, filed 29 Oct 2026.